Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
4:45 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		ORBIMED CAPITAL LLC0
0%		-2,583,821decrease
(Position Closed)		View
2023-02-14
4:45 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		RA CAPITAL MANAGEMENT L.P.0
0%		-2,246,503decrease
(Position Closed)		View
2023-02-14
4:07 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		Venrock Healthcare Capital Partners III L.P.2,208,812
6.4%		136,803increase
(+6.60%)		View
2023-02-14
1:13 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Boxer Capital LLC698,861
2%		-1,540,000decrease
(-68.78%)		View
2023-02-14
11:03 am
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Ikarian Capital LLC460,416
1.3%		-1,289,627decrease
(-73.69%)		View
2023-02-13
09:06 am
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		BlackRock Inc.
BLK		1,727,829
5%		1,727,829increase
(New Position)		View
2023-01-19
09:19 am
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		GOLDMAN SACHS GROUP INC
GS		2,750,385
8%		2,750,385increase
(New Position)		View
2023-01-18
4:40 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		INTEGRATED CORE STRATEGIES (US) LLC2,195,029
6.4%		290,732increase
(+15.27%)		View
2022-10-31
4:40 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		INTEGRATED CORE STRATEGIES (US) LLC1,904,297
6.3%		1,904,297increase
(New Position)		View
2022-10-24
12:46 pm
Sale		13DMilestone Pharmaceuticals Inc.
MIST		Novo Holdings A/S1,378,538
4.6%		-719,175decrease
(-34.28%)		View
2022-09-26
4:04 pm
Purchase		13DMilestone Pharmaceuticals Inc.
MIST		Novo Holdings A/S2,097,713
7%		16,828increase
(+0.81%)		View
2022-09-19
9:14 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		Venrock Healthcare Capital Partners III L.P.2,072,009
6.9%		2,072,009increase
(New Position)		View
2022-02-14
4:54 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Boxer Capital LLC2,238,861
7.5%		-238,333decrease
(-9.62%)		View
2022-02-14
4:36 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Ikarian Capital LLC1,750,043
5.9%		-86,502decrease
(-4.71%)		View
2022-02-14
4:11 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		RA CAPITAL MANAGEMENT L.P.2,246,503
7.5%		-81,211decrease
(-3.49%)		View
2022-02-14
08:03 am
Sale		13GMilestone Pharmaceuticals Inc.
MIST		RTW INVESTMENTS LP4,315,102
14.4%		-99decrease
(-0.00%)		View
2022-02-11
4:32 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		ORBIMED CAPITAL LLC2,583,821
8.7%		90,712increase
(+3.64%)		View
2021-02-16
4:57 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		Boxer Capital LLC2,477,194
8.3%		700,000increase
(+39.39%)		View
2021-02-16
4:39 pm
Purchase		13GMilestone Pharmaceuticals Inc.
MIST		RA CAPITAL MANAGEMENT L.P.2,327,714
7.8%		2,327,714increase
(New Position)		View
2021-02-16
12:24 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		PRICE T ROWE ASSOCIATES INC374,957
1.2%		-911,550decrease
(-70.85%)		View
Goto 0, 1, Next